China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time ...

Discover how U.S. biotechs can learn from China's success in affordable, high-quality drug development. Read more here.

U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

The sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...